Evidence map›Paper›PMID 33420194›Full record

ArticleScientific reports2021

Anti-tumour activity of deer growing antlers and its potential applications in the treatment of malignant gliomas.

Louis Chonco, Tomás Landete-Castillejos, Gemma Serrano-Heras, Martina Pérez Serrano, Francisco Javier Pérez-Barbería, Carlos González-Armesto, Andrés García, Carlos de Cabo, Jose Manuel Lorenzo, Chunyi Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. 3D-ASC-Exos as a novel drug carrier for glioma treatment.Frontiers in cell and developmental biology · 2025
    Article
  6. Optimizing protein yield from growing deer antlers.Frontiers in bioengineering and biotechnology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Louis ChoncoResearch Unit, Complejo Hospitalario Universitario de Albacete, 02006, Albacete, Spain. louischonco@gmail.com.
Tomás Landete-CastillejosAnimal Science Techniques Applied to Wildlife Management Research Group, Instituto de Investigación en Recursos Cinegéticos, Universidad de Castilla-La Mancha, 02071, Albacete, Spain.
Gemma Serrano-HerasResearch Unit, Complejo Hospitalario Universitario de Albacete, 02006, Albacete, Spain.
Martina Pérez SerranoAnimal Science Techniques Applied to Wildlife Management Research Group, Instituto de Investigación en Recursos Cinegéticos, Universidad de Castilla-La Mancha, 02071, Albacete, Spain.
Francisco Javier Pérez-BarberíaAnimal Science Techniques Applied to Wildlife Management Research Group, Instituto de Investigación en Recursos Cinegéticos, Universidad de Castilla-La Mancha, 02071, Albacete, Spain.
Carlos González-ArmestoResearch Unit, Complejo Hospitalario Universitario de Albacete, 02006, Albacete, Spain.
Andrés GarcíaAnimal Science Techniques Applied to Wildlife Management Research Group, Instituto de Investigación en Recursos Cinegéticos, Universidad de Castilla-La Mancha, 02071, Albacete, Spain.
Carlos de CaboResearch Department, Neuropsychopharmacology Unit, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Jose Manuel LorenzoCentro Tecnológico de la Carne de Galicia, rúa Galicia n° 4, Parque Tecnológico de Galicia, San Cibrao das Viñas, 32900, Ourense, Spain.
Chunyi LiInstitute of Antler Science and Product Technology, Changchun Sci-Tech University, Corner of Pudong Road and Suzhou Bei Street, Changchun, Jilin, People's Republic of China.
Tomás SeguraResearch Unit, Complejo Hospitalario Universitario de Albacete, 02006, Albacete, Spain. tseguram@gmail.com.
Complejo Hospitalario Universitario de Albacete · ESInstituto de Investigación en Recursos Cinegéticos · ESUniversity of Castilla-La Mancha · ESCentro Tecnológico de Automoción de Galicia · ESChangchun University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent study showed that antlers have evolved a high rate of growth due to the expression of proto-oncogenes and that they have also evolved to express several tumour suppressor genes to control the risk of cancer. This may explain why deer antler velvet (DAV) extract shows anti-tumour activity. The fast growth of antler innervation through the velvet in close association to blood vessels provides a unique environment to study the fast but non-cancerous proliferation of heterogeneous cell populations. We set out to study the anti-cancer effect of DAV in glioblastoma (GB) cell lines in comparison with temozolomide, a chemotherapeutic drug used to treat high-grade brain tumours. Here we report, for the first time, that DAV extract from the tip, but not from mid-parts of the antler, exhibits an anti-tumour effect in GB cell lines (T98G and A172) while being non-toxic in non-cancerous cell lines (HEK293 and HACAT). In T98G cells, DAV treatment showed reduced proliferation (37.5%) and colony-formation capacity (84%), inhibited migration (39%), induced changes in cell cycle progression, and promoted apoptosis. The anticancer activity of DAV extract as demonstrated by these results may provide a new therapeutic strategy for GB treatment.

Indexed as

AnimalsAntineoplastic AgentsAntlersApoptosisCell CycleCell Line, TumorDeerGliomaHumansTemozolomideTissue ExtractsAntineoplastic AgentsTemozolomideTissue Extracts

Identifiers

PMID33420194
PMCPMC7794318
OpenAlexW3119537040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.